Doximity, Inc.

Equities

DOCS

US26622P1075

Internet Services

Market Closed - Nyse 16:00:02 2024-05-17 EDT 5-day change 1st Jan Change
28.03 USD +18.07% Intraday chart for Doximity, Inc. +19.94% -0.04%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Softer Friday Afternoon MT
Doximity's Shares Rise After Truist Securities Price Target Raise Following Fiscal Q4 Results MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday MT
Sector Update: Health Care MT
Rate Outlooks Quell Wall Street Pre-Bell; Asia Mixed, Europe Off MT
Truist Securities Adjusts Price Target on Doximity to $31 From $29 After 'Strong' Fiscal Q4 Results, Keeps Hold Rating MT
Transcript : Doximity, Inc., Q4 2024 Earnings Call, May 16, 2024
Doximity Fiscal Q4 Non-GAAP EPS, Revenue Rise; Q1, FY Outlook Set; Shares Jump After Hours MT
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on November 9, 2023. CI
Doximity, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Doximity, Inc. announces an Equity Buyback for $500 million worth of its shares. CI
Doximity Guides For Q1 Revenue of $119.5-$120.5 Million, vs CIQ Analyst Consensus of $119 Million; FY 2025 Revenue Seen at $506-$518 Million, vs Consensus of $520 Million MT
Earnings Flash (DOCS) DOXIMITY Posts Q4 EPS $0.25, vs. Street Est of $0.20 MT
Earnings Flash (DOCS) DOXIMITY Posts Q4 Revenue $118.1M, vs. Street Est of $116.4M MT
Doximity, Inc. Provides Financial Guidance for the First Quarter Ending June 30, 2024 and Full Year Ending March 31, 2025 CI
North American Morning Briefing : Tech Still in -2- DJ
JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25 MT
Doximity Business Under Pressure as Underlying Sales Falling, Jehoshaphat Research Says MT
JPMorgan Adjusts Price Target on Doximity to $25 From $22, Maintains Underweight Rating MT
Leerink Partners Initiates Doximity at Market Perform Rating With $32 Price Target MT
Jefferies Raises Doximity's Price Target to $35 From $30, Buy Rating Kept MT
Wells Fargo Adjusts Price Target on Doximity to $27 From $25, Maintains Equalweight Rating MT
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on June 6, 2023. CI
Doximity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Doximity, Inc., Q3 2024 Earnings Call, Feb 08, 2024
Chart Doximity, Inc.
More charts
Doximity, Inc. provides a digital platform for United States (U.S) medical professionals. The Company's cloud-based platform provides tools to its members, which help them to collaborate with colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with medical news and research, and manage careers. The Company supports physicians in practice of medicine with mobile and clinical workflow tools, such as voice and video telehealth, secure messaging and digital faxing. The Company's platform offers marketing, hiring, and telehealth solutions. Its marketing solutions enable pharmaceutical and health system customers to get content, services, and peer connections to medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its telehealth solutions consist of software tools that include voice and video dialers, designed to connect patients with care providers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
28.03 USD
Average target price
29.85 USD
Spread / Average Target
+6.48%
Consensus
  1. Stock Market
  2. Equities
  3. DOCS Stock
  4. News Doximity, Inc.
  5. JPMorgan Adjusts Price Target on Doximity to $30 From $60, Maintains Underweight Rating
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW